Evidence map›Paper›PMID 28804629›Full record

ArticleBiomedical reports2017

Clinical presentation and treatment of gastric metastasis from other malignancies of solid organs.

Tsutomu Namikawa, Eri Munekage, Maho Ogawa, Toyokazu Oki, Masaya Munekage, Hiromichi Maeda, Hiroyuki Kitagawa, Takeki Sugimoto, Michiya Kobayashi, Kazuhiro Hanazaki

Abstract read
In one paragraph

Article in Biomedical reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. A Case Series of Gastric Metastatic Growths.Diseases (Basel, Switzerland) · 2022
    Article
  7. Application ofJournal of oncology · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tsutomu NamikawaDepartment of Surgery, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.
Eri MunekageDepartment of Surgery, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.
Maho OgawaDepartment of Surgery, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.
Toyokazu OkiDepartment of Surgery, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.
Masaya MunekageDepartment of Surgery, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.
Hiromichi MaedaCancer Treatment Center, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.
Hiroyuki KitagawaDepartment of Surgery, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.
Takeki SugimotoDepartment of Surgery, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.
Michiya KobayashiCancer Treatment Center, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.
Kazuhiro HanazakiDepartment of Surgery, Kochi Medical School, Nankoku, Kochi 783-8505, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of the present study was to analyze the clinicopathologic features and treatment outcomes of gastric metastasis from other malignancies of solid organs. A review was conducted of patients with metastatic tumors in the stomach from other malignancies of solid organs detected endoscopically at the Department of Surgery, Kochi Medical School, from January 1991 to December 2015. Seven patients (four men and three women), with a median age of 64 years (range, 42-71 years), had metastatic gastric tumors. Median tumor size was 7.3 cm (range, 2.5-12.0 cm). The primary malignancy leading to metastatic tumors in the stomach was esophageal cancer in three patients, breast cancer in two patients, renal cell carcinoma in one patient, and ovarian cancer in one patient. Gastric metastasis presented as solitary lesions in six patients and as multiple lesions in one patient. Four patients had solitary gastric metastasis, whereas three had multiple metastases in other organs. The median tumor size was significantly smaller in patients with solitary rather than multiple metastases (4.6 vs. 12.0 cm, respectively; P=0.038). Three patients received systemic therapy and four underwent surgical resection of the metastatic tumor, and of these, only one was alive 58 months after surgery. Clinicians should be aware of the possible existence of metastatic gastric cancer, especially in breast carcinoma and esophageal cancer. Surgical resection may considerably improve patients' quality of life, and could be of benefit when there is a risk of bleeding and/or a solitary metastasis.

Indexed as

gastric cancergastric metastasismetastatic gastric tumorsolitary metastasis

Identifiers

PMID28804629
PMCPMC5526074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.